Cargando…
Identifying prevalence and risk factors for metformin non-persistence: a retrospective cohort study using an electronic health record
OBJECTIVES: Non-persistence may be a significant barrier to the use of metformin. Our objective was to assess reasons for metformin non-persistence, and whether initial metformin dosing or use of extended release (ER) formulations affect persistence to metformin therapy. DESIGN: Retrospective cohort...
Autores principales: | Flory, James H, Keating, Scott Justin, Siscovick, David, Mushlin, Alvin I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059278/ https://www.ncbi.nlm.nih.gov/pubmed/30037872 http://dx.doi.org/10.1136/bmjopen-2018-021505 |
Ejemplares similares
-
Overcoming barriers to the use of metformin: patient and provider perspectives
por: Flory, James H, et al.
Publicado: (2019) -
Effect of Cost and Formulation on Persistence and Adherence to Initial Metformin Therapy for Type 2 Diabetes
por: Flory, James H., et al.
Publicado: (2020) -
Acarbose-metformin is more effective in glycemic variability control than repaglinide-metformin in T2DM patients inadequately controlled with metformin: a retrospective cohort study
por: Du, Guoli, et al.
Publicado: (2020) -
Metformin initiation and renal impairment: a cohort study in Denmark and the UK
por: Christiansen, Christian Fynbo, et al.
Publicado: (2015) -
A cohort study of trends in the prevalence of pregestational diabetes in pregnancy recorded in UK general practice between 1995 and 2012
por: Coton, Sonia J, et al.
Publicado: (2016)